ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 96
  • Next Page »
Search Again »
  • Abstract Number: 0991 • ACR Convergence 2021

    Does Diet Affect Gout Risk Differently Among Genetically Predisposed Women?: Prospective Female Cohort Study Findings over 34 Years

    Chio Yokose1, Natalie McCormick2, Na Lu3, Amit Joshi2 and Hyon K. Choi4, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital, Lexington, MA

    Background/Purpose: Gout has long been considered a male disease. However, several recent analyses of the Global Burden of Disease (GBD) Study report a disproportionate worsening…
  • Abstract Number: 1078 • ACR Convergence 2021

    Rural Veterans with Gout – “Rheum” for Improvement

    Jennifer Barton1, Elizabeth Hooker2, Christopher Larsen2, Rachel Matsumoto2 and Allison O'Neill2, 1VA Portland Health Care System/OHSU, Portland, OR, 2Center to Improve Veteran Involvement in Care/VA Portland Health Care System, Portland, OR

    Background/Purpose: Gout is a form of inflammatory arthritis that can be “cured” with appropriate urate-lowering therapy to achieve a goal uric acid of 6mg/dL or…
  • Abstract Number: 1099 • ACR Convergence 2021

    Characteristics and Outcomes of Myocardial Infarction in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Gout and Osteoarthritis Patients Using the National Inpatient Sample Database from 2002-2018

    Sonia Gupta1, Vinay thallapally2, Sarah Aurit2, Rouhin sen3 and Joseph Nahas2, 1Creighton University School of Medicine, Omaha, NE, 2Creighton University, Omaha, NE, 3Colorado University Anschutz Medical Campus, Denver, CO

    Background/Purpose: Patients with the autoimmune rheumatic disease have an increased risk of acute myocardial infarction (MI). Our study was designed to compare the prevalence, characteristics…
  • Abstract Number: 1184 • ACR Convergence 2021

    Voluntary Online Gout Module: Housestaff Utilization and Efficacy

    Sarah Tarplin1, Susan Kroop2 and Catherine Deffendall2, 1Vanderbilt Universty Medical Center, nashville, TN, 2Vanderbilt University, Nashville, TN

    Background/Purpose: All Internal Medicine (IM) physicians should be competent in gout diagnosis and management. The purpose of this study is to assess learner engagement with…
  • Abstract Number: 1449 • ACR Convergence 2021

    Is Repeat Serum Urate Testing Superior to a Single Test to Predict Incident Gout over Time?

    Sarah Stewart1, Amanda Phipps-Green2, Gregory Gamble1, Lisa Stamp3, William Taylor4, Tuhina Neogi5, Tony Merriman6 and Nicola Dalbeth1, 1University of Auckland, Auckland, New Zealand, 2University of Otago Dunedin, Dunedin, New Zealand, 3University of Otago, Christchurch, Christchurch, New Zealand, 4University of Otago Wellington, Auckland, New Zealand, 5Boston University School of Medicine, Boston, MA, 6University of Alabama at Birmingham, Dunedin, New Zealand

    Background/Purpose: Elevated serum urate is the most important risk factor for developing gout. However, in longitudinal cohort studies, a small proportion of people with normal…
  • Abstract Number: 1565 • ACR Convergence 2021

    Causal Mediation Analysis of the Relationship of Canakinumab’s Protective Effect Against Gout Flares and High-sensitivity C-reactive Protein in the CANTOS Trial

    Kazuki Yoshida1, Robert J. Glynn1, Hyon K. Choi2, Brendan M. Everett1, Yi Li3, Jean G. MacFadyen1, Paul M. Ridker1 and DH Solomon1, 1Brigham and Women's Hospital, Boston, MA, 2Massachusetts General Hospital, Lexington, MA, 3Harvard T.H. Chan School of Public Health, Boston, MA

    Background/Purpose: Previous analyses in the CANTOS trial demonstrated a benefit of canakinumab (CAN; IL-1β inhibitor) on gout flares. We aimed to quantify the mediating role…
  • Abstract Number: 1567 • ACR Convergence 2021

    Pharmacokinetics and Pharmacodynamics of Anthocyanins After Oral Administration of Oral Tart Cherry Juice Concentrate to Gout Patients

    Luigi Brunetti1, Lujing Wang2, Andrew Wassef2, Anita Brinker3, Brian T Buckley4, Peter Lipsky5, Ah-Ng Kong2 and Naomi Schlesinger6, 1Rutgers The State University of New Jersey, Piscataway, NJ, 2Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 3Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey,, Piscataway, NJ, 4Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, Piscataway, NJ, 5AMPEL BioSolutions, Charlottesville, VA, 6Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

    Background/Purpose: Tart cherries (TC) contain high levels of anthocyanins that exert potent antioxidant and anti-inflammatory effects. Approximately 50% of gout patients report using TC to…
  • Abstract Number: 1571 • ACR Convergence 2021

    Elevated Lactate, Procalcitonin Levels and SIRS (Systemic Inflammatory Response Syndrome) in a Subset of Patients with Gout

    Christopher Podgorski1, Paula Skarda2 and Elie Gertner3, 1Department of Medicine, University of Minnesota Medical School, Saint Paul, MN, 2Department of Medicine, Regions Hospital, University of Minnesota Medical School, Saint Paul, MN, 3Section of Rheumatology, Regions Hospital and Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN

    Background/Purpose: The intense inflammatory cascade of acute gouty inflammation makes it difficult to differentiate clinically between acute gouty inflammation and sepsis, particularly since they can…
  • Abstract Number: 1572 • ACR Convergence 2021

    Ultrasound Signs of Gout in a Population with Asymptomatic Hyperuricemia

    Bilal Bengana1, Aicha Ladjouze2, Nabil Baramtane Raaf3, Chaffa Aimeur4, Soraya Ayoub5, Abdenour Boukabous6 and Salima Lefkir-Tafiani7, 1University Hospital of Beni Messous Algiers - Rheumatology Department, Algiers, Algeria, 2Specialized hospital establishment of Benaknoune, Rheumatology, Algiers, Algeria, 3Hospital of Bitraria, Biochemistry, El Biar, Algiers, Algeria, 4University hospital of Mustapha Bacha, Radiology, Sidi Mhamed, Algiers, Algeria, 5University hospital of Beni Messous, Internal Medicine, BeniMessous, Algiers, Algeria, 6University Hospital of Beni Messous Algiers- Rheumatology Department, Algiers, Algeria, 7University Hospital of Beni Messous Algiers - Rheumatology Department, Benimessous, Algeria

    Background/Purpose: Hyperuricemia is a common biological abnormality, often clinically asymptomatic. However, it can announce a gout and be linked to many diseases such as metabolic…
  • Abstract Number: 1573 • ACR Convergence 2021

    Vascular Monosodium Urate Crystal Deposition in Gout: A Dual-energy CT and Microscopy Study of Cadaveric Donors

    Nicola Dalbeth1, Mariam Alhilali1, Peter Riordan1, Ravi Narang1, Ashika Chhana1, Sue McGlashan1, Anthony Doyle1 and MARIANO ANDRES2, 1University of Auckland, Auckland, New Zealand, 2Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain

    Background/Purpose: Cardiovascular disease is a common comorbidity in people with gout. A hypothesized link between cardiovascular disease and gout is the deposition of monosodium urate…
  • Abstract Number: 1574 • ACR Convergence 2021

    Comparison of Urate Quantification in Gout and Asymptomatic Hyperuricemia by Ultrasound and Dual Energy Computed Tomography

    Rachael Flood1, Aamir Saeed2, Kate Harrington1, Conor Shortt1, Ronan Mullan1 and David Kane1, 1Tallaght University Hospital, Dublin, Ireland, 2Worcestershire Acute Hospitals NHS Trust., Worcester, United Kingdom

    Background/Purpose: The diagnostic gold standard for gout remains aspiration and identification of monosodium urate (MSU) crystals under polarised light microscopy. Joint aspiration is invasive and…
  • Abstract Number: 1576 • ACR Convergence 2021

    Development of a Plain Radiographic Scoring System for New Bone Formation in Gout

    Chang-Nam Son1, Ken Cai2, John Ferrier3, Yun-Jung Tsai3, Thomas Bardin4, Anthony Doyle5 and Nicola Dalbeth5, 1Keimyung University School of Medicine, Daegu, Republic of Korea, 2University of Auckland, Sydney, Australia, 3Department of Radiology, Auckland District Health Board, Auckland, New Zealand, 4Hôpital Lariboisiere, Paris, France, 5University of Auckland, Auckland, New Zealand

    Background/Purpose: Features of new bone formation (NBF) such as sclerosis and spurs are common on plain radiography in tophaceous gout. While a plain radiographic damage…
  • Abstract Number: 1577 • ACR Convergence 2021

    Interleukin-37: Associations of Plasma Levels and Genetic Variants in Gout

    Adela Navratilova1, Veronika Voclonová2, Hana Hulejová2, Lucie Andrés Cerezo1, Markéta Pavlíková3, Viktor Bečvář2, Jakub Zavada1, Karel Pavelka4, Ladislav Senolt4 and Blanka Stiburkova5, 1Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, 3Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic, 4Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 5Institute of Rheumatology and Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: IL-37 is an anti-inflammatory cytokine, member of IL-1 family, related to inflammatory and autoimmune diseases. Here we aimed to investigate the association of genetic…
  • Abstract Number: 1579 • ACR Convergence 2021

    Phenome-Wide Association of Gout Risk Loci

    Oleg Stens1, Vivian Trang2, Steven Cao2, Robert Terkeltaub1 and Rany Salem2, 1University of California San Diego School of Medicine, La Jolla, CA, 2University of California San Diego School of Public Health, La Jolla, CA

    Background/Purpose: Gout is a complex disease involving changes in urate biology and inflammatory responses, and is associated with comorbidities including metabolic syndrome and cardiorenal disease.…
  • Abstract Number: 1580 • ACR Convergence 2021

    Whole Blood Gene Expression and eQTL Analysis Implicate GGT7 and FADS2 in Gout Pathogenesis

    Richard Reynolds1, Riku Takei1, Jeffrey Edberg1, Nicholas Sumpter1, Tony Merriman2 and Megan Leask1, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Dunedin, New Zealand

    Background/Purpose: Gene expression studies of whole blood represent a powerful approach for understanding the pathogenesis of gout because differentially expressed transcripts may reflect the activation…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 96
  • Next Page »
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology